{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T21:31:58Z","timestamp":1787347918091,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Edukacji i Nauki","doi-asserted-by":"publisher","award":["PN\/01\/0003\/2022"],"award-info":[{"award-number":["PN\/01\/0003\/2022"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41130-0","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:15:40Z","timestamp":1772788540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cannabidiolic acid as a modulator of lipid metabolism in the liver of rats with metabolic-associated steatotic liver disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Piotr Franciszek","family":"Kurzyna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patryk","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Zwierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Harasim-Symbor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Dzi\u0119cio\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ryszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Konstantynowicz-Nowicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"41130_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542\u20131556 (2023).","journal-title":"J. Hepatol."},{"key":"41130_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"41130_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta\u2010analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"41130_CR4","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai, P. S. et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta\u2010analysis. Hepatology 65, 1557\u20131565 (2017).","journal-title":"Hepatology"},{"key":"41130_CR5","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen, D. H., Lykkesfeldt, J. & Tveden-Nyborg, P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell. Mol. Life Sci. 75, 3313\u20133327 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"41130_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.cmet.2012.03.005","volume":"15","author":"FR Jornayvaz","year":"2012","unstructured":"Jornayvaz, F. R. & Shulman, G. I. Diacylglycerol activation of protein kinase C\u03b5 and hepatic insulin resistance. Cell Metab 15, 574\u2013584 (2012).","journal-title":"Cell Metab"},{"key":"41130_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s44324-024-00022-5","volume":"2","author":"S Raza","year":"2024","unstructured":"Raza, S., Rajak, S., Yen, P. M. & Sinha, R. A. Autophagy and hepatic lipid metabolism: Mechanistic insight and therapeutic potential for MASLD. NPJ Metab. Health Dis. 2, 19 (2024).","journal-title":"NPJ Metab. Health Dis."},{"key":"41130_CR8","doi-asserted-by":"publisher","first-page":"16381","DOI":"10.1073\/pnas.1113359108","volume":"108","author":"N Kumashiro","year":"2011","unstructured":"Kumashiro, N. et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc. Natl. Acad. Sci. U. S. A. 108, 16381\u201316385 (2011).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"41130_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1294267","author":"G Rao","year":"2023","unstructured":"Rao, G. et al. Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: From mechanism to the clinic. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2023.1294267 (2023).","journal-title":"Front. Med."},{"key":"41130_CR10","doi-asserted-by":"publisher","first-page":"E969","DOI":"10.1152\/ajpendo.00497.2007","volume":"294","author":"M Stefanovic-Racic","year":"2008","unstructured":"Stefanovic-Racic, M. et al. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am. J. Physiol. Endocrinol. Metab. 294, E969\u2013E977 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"41130_CR11","doi-asserted-by":"publisher","first-page":"E321","DOI":"10.1152\/ajpendo.1998.274.2.E321","volume":"274","author":"F Diraison","year":"1998","unstructured":"Diraison, F. & Beylot, M. Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification. Am. J. Physiol. Endocrinol. Metab. 274, E321\u2013E327 (1998).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"41130_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115, 1343\u20131351 (2005).","journal-title":"J. Clin. Invest."},{"key":"41130_CR13","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1194\/jlr.M052308","volume":"55","author":"JAG Duarte","year":"2014","unstructured":"Duarte, J. A. G. et al. A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice. J. Lipid Res. 55, 2541\u20132553 (2014).","journal-title":"J. Lipid Res."},{"key":"41130_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep27541","volume":"6","author":"GM Kowalski","year":"2016","unstructured":"Kowalski, G. M. et al. Reversing diet-induced metabolic dysregulation by diet switching leads to altered hepatic de novo lipogenesis and glycerolipid synthesis. Sci. Rep. 6, 27541 (2016).","journal-title":"Sci. Rep."},{"key":"41130_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep46658","volume":"7","author":"F Chiappini","year":"2017","unstructured":"Chiappini, F. et al. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Sci. Rep. 7, 46658 (2017).","journal-title":"Sci. Rep."},{"key":"41130_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15090595","volume":"15","author":"M Banaszak","year":"2025","unstructured":"Banaszak, M., G\u00f3rna, I. & Drzyma\u0142a-Czy\u017c, S. Fatty acid profile and desaturase activity in obesity: Roles, mechanisms, and clinical relevance. Metabolites 15, 595 (2025).","journal-title":"Metabolites"},{"key":"41130_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.iliver.2024.100131","volume":"3","author":"P Yadav","year":"2024","unstructured":"Yadav, P. et al. New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products. iLIVER 3, 100131 (2024).","journal-title":"iLIVER"},{"key":"41130_CR18","doi-asserted-by":"crossref","unstructured":"Andre, C. M., Hausman, J.-F. & Guerriero, G. Cannabis sativa: The Plant of the Thousand and One Molecules. Front Plant Sci 7, (2016).","DOI":"10.3389\/fpls.2016.00019"},{"key":"41130_CR19","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.febslet.2007.05.043","volume":"581","author":"F Taura","year":"2007","unstructured":"Taura, F. et al. Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis sativa. FEBS Lett. 581, 2929\u20132934 (2007).","journal-title":"FEBS Lett."},{"key":"41130_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94212-6","volume":"11","author":"LL Anderson","year":"2021","unstructured":"Anderson, L. L., Etchart, M. G., Bahceci, D., Golembiewski, T. A. & Arnold, J. C. Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations. Sci. Rep. 11, 14948 (2021).","journal-title":"Sci. Rep."},{"key":"41130_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.00505","author":"JJ Wakshlag","year":"2020","unstructured":"Wakshlag, J. J. et al. Pharmacokinetics of cannabidiol, cannabidiolic acid, \u03949-tetrahydrocannabinol, tetrahydrocannabinolic acid and related metabolites in canine serum after dosing with three oral forms of hemp extract. Front. Vet. Sci. https:\/\/doi.org\/10.3389\/fvets.2020.00505 (2020).","journal-title":"Front. Vet. Sci."},{"key":"41130_CR22","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s00213-016-4378-7","volume":"233","author":"EM Rock","year":"2016","unstructured":"Rock, E. M., Connolly, C., Limebeer, C. L. & Parker, L. A. Effect of combined oral doses of \u03949-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models. Psychopharmacology 233, 3353\u20133360 (2016).","journal-title":"Psychopharmacology"},{"key":"41130_CR23","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.3390\/molecules25112638","volume":"25","author":"M Formato","year":"2020","unstructured":"Formato, M. et al. (-)-Cannabidiolic acid, a still overlooked bioactive compound: An introductory review and preliminary research. Molecules 25, 2638 (2020).","journal-title":"Molecules"},{"key":"41130_CR24","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.jhep.2015.01.001","volume":"62","author":"C Silvestri","year":"2015","unstructured":"Silvestri, C. et al. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. J. Hepatol. 62, 1382\u20131390 (2015).","journal-title":"J. Hepatol."},{"key":"41130_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000534610","volume":"6","author":"V Degrave","year":"2023","unstructured":"Degrave, V. et al. Effects of full-spectrum Cannabis oil with a cannabidiol: Tetrahydrocannabinol 2:1 ratio on the mechanisms involved in hepatic steatosis and oxidative stress in rats fed a sucrose-rich diet. Med. Cannabis Cannabinoids 6, 170\u2013183 (2023).","journal-title":"Med. Cannabis Cannabinoids"},{"key":"41130_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956688","author":"J Zhou","year":"2022","unstructured":"Zhou, J. et al. Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.956688 (2022).","journal-title":"Front. Immunol."},{"key":"41130_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11130-023-01132-z","volume":"79","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y., Chen, X., Su, T., Yuan, M. & Sun, X. Kiwifruit peel extract improves the alterations in lipid metabolism in high-fat diet-fed model rats. Plant Foods Hum. Nutr. 79, 113\u2013119 (2024).","journal-title":"Plant Foods Hum. Nutr."},{"key":"41130_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813797","volume":"24","author":"A Eitan","year":"2023","unstructured":"Eitan, A., Gover, O., Sulimani, L., Meiri, D. & Schwartz, B. The effect of orally administered \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD) on obesity parameters in mice. Int. J. Mol. Sci. 24, 13797 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"41130_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejphar.2016.03.049","volume":"780","author":"Y Cao","year":"2016","unstructured":"Cao, Y. et al. Emodin ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle. Eur. J. Pharmacol. 780, 194\u2013201 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"41130_CR30","first-page":"985","volume":"1864","author":"AL McIntosh","year":"2019","unstructured":"McIntosh, A. L. et al. Effect of liver fatty acid binding protein (L-FABP) gene ablation on lipid metabolism in high glucose diet (HGD) pair-fed mice. Biochimica et Biophysica Acta BBA Mol. Cell Biol. Lipids 1864, 985\u20131004 (2019).","journal-title":"Biochimica et Biophysica Acta BBA Mol. Cell Biol. Lipids"},{"key":"41130_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/can.2020.0013","volume":"5","author":"T Assa-Glazer","year":"2020","unstructured":"Assa-Glazer, T. et al. Cannabis extracts affected metabolic syndrome parameters in mice fed high-fat\/cholesterol diet. Cannabis Cannabinoid Res. 5, 202\u2013214 (2020).","journal-title":"Cannabis Cannabinoid Res."},{"key":"41130_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11418-022-01647-w","volume":"77","author":"L-S Ran","year":"2023","unstructured":"Ran, L.-S. et al. Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease. J. Nat. Med. 77, 73\u201386 (2023).","journal-title":"J. Nat. Med."},{"key":"41130_CR33","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1053\/j.gastro.2006.02.006","volume":"130","author":"H Doege","year":"2006","unstructured":"Doege, H. et al. Targeted deletion of FATP5 reveals multiple functions in liver metabolism: Alterations in hepatic lipid homeostasis. Gastroenterology 130, 1245\u20131258 (2006).","journal-title":"Gastroenterology"},{"key":"41130_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00535-019-01633-2","volume":"55","author":"K Enooku","year":"2020","unstructured":"Enooku, K. et al. Hepatic FATP5 expression is associated with histological progression and loss of hepatic fat in NAFLD patients. J. Gastroenterol. 55, 227\u2013243 (2020).","journal-title":"J. Gastroenterol."},{"key":"41130_CR35","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","volume":"142","author":"F Magkos","year":"2012","unstructured":"Magkos, F. et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology 142, 1444-1446.e2 (2012).","journal-title":"Gastroenterology"},{"key":"41130_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","volume":"3","author":"Z Li","year":"2006","unstructured":"Li, Z. et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 3, 321\u2013331 (2006).","journal-title":"Cell Metab."},{"key":"41130_CR37","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.2337\/db09-1380","volume":"59","author":"AA Wendel","year":"2010","unstructured":"Wendel, A. A. et al. Glycerol-3-phosphate acyltransferase 1 deficiency in ob\/ob Mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity. Diabetes 59, 1321\u20131329 (2010).","journal-title":"Diabetes"},{"key":"41130_CR38","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1194\/jlr.M400010-JLR200","volume":"45","author":"D Lind\u00e9n","year":"2004","unstructured":"Lind\u00e9n, D. et al. Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. J. Lipid Res. 45, 1279\u20131288 (2004).","journal-title":"J. Lipid Res."},{"key":"41130_CR39","doi-asserted-by":"publisher","first-page":"13087","DOI":"10.1074\/jbc.M800533200","volume":"283","author":"BN Reid","year":"2008","unstructured":"Reid, B. N. et al. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J. Biol. Chem. 283, 13087\u201313099 (2008).","journal-title":"J. Biol. Chem."},{"key":"41130_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.24006","volume":"53","author":"KT Ong","year":"2011","unstructured":"Ong, K. T., Mashek, M. T., Bu, S. Y., Greenberg, A. S. & Mashek, D. G. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology 53, 116\u2013126 (2011).","journal-title":"Hepatology"},{"key":"41130_CR41","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s11745-015-4061-5","volume":"50","author":"T Liu","year":"2015","unstructured":"Liu, T. et al. High-fat diet alters serum fatty acid profiles in obesity prone rats: Implications for in vitro studies. Lipids 50, 997\u20131008 (2015).","journal-title":"Lipids"},{"key":"41130_CR42","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s10571-019-00692-6","volume":"39","author":"M Rey","year":"2019","unstructured":"Rey, M., Kruse, M. S., Magrini-Huam\u00e1n, R. N. & Coirini, H. High-fat diets and LXRs expression in rat liver and hypothalamus. Cell. Mol. Neurobiol. 39, 963\u2013974 (2019).","journal-title":"Cell. Mol. Neurobiol."},{"key":"41130_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/nu17061034","author":"Q Zhu","year":"2025","unstructured":"Zhu, Q., Yang, Q., Shen, L., Xu, M. & Liu, M. The impact of cannabidiol (CBD) on lipid absorption and lymphatic transport in rats. Nutrients https:\/\/doi.org\/10.3390\/nu17061034 (2025).","journal-title":"Nutrients"},{"key":"41130_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.01006","author":"M Melis","year":"2017","unstructured":"Melis, M. et al. Polymorphism rs1761667 in the CD36 gene is associated to changes in fatty acid metabolism and circulating endocannabinoid levels distinctively in normal weight and obese subjects. Front. Physiol. https:\/\/doi.org\/10.3389\/fphys.2017.01006 (2017).","journal-title":"Front. Physiol."},{"key":"41130_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127368","volume":"10","author":"S Jacobs","year":"2015","unstructured":"Jacobs, S. et al. Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with proxies of liver fat accumulation in the EPIC-Potsdam study. PLoS ONE 10, e0127368 (2015).","journal-title":"PLoS ONE"},{"key":"41130_CR46","doi-asserted-by":"crossref","unstructured":"Crescenzo, R. et al. Polyunsaturated Fatty Acids Stimulate De novo Lipogenesis and Improve Glucose Homeostasis during Refeeding with High Fat Diet. Front Physiol 8, (2017).","DOI":"10.3389\/fphys.2017.00178"},{"key":"41130_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252011289","volume":"25","author":"P Li","year":"2024","unstructured":"Li, P. et al. 6-gingerol inhibits de novo lipogenesis by targeting stearoyl-CoA desaturase to alleviate fructose-induced hepatic steatosis. Int. J. Mol. Sci. 25, 11289 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"41130_CR48","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3390\/ijms22136900","volume":"22","author":"A Hliwa","year":"2021","unstructured":"Hliwa, A., Ramos-Molina, B., Laski, D., Mika, A. & Sledzinski, T. The role of fatty acids in non-alcoholic fatty liver disease progression: An update. Int. J. Mol. Sci. 22, 6900 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"41130_CR49","doi-asserted-by":"crossref","unstructured":"Frid\u00e9n, M. et al. Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease. Front Med (Lausanne) 8, (2022).","DOI":"10.3389\/fmed.2021.814951"},{"key":"41130_CR50","doi-asserted-by":"publisher","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi, H., Bronk, S. F., Werneburg, N. W. & Gores, G. J. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J. Biol. Chem. 281, 12093\u201312101 (2006).","journal-title":"J. Biol. Chem."},{"key":"41130_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3945\/jn.112.171322","volume":"143","author":"CM Depner","year":"2013","unstructured":"Depner, C. M., Philbrick, K. A. & Jump, D. B. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr mouse model of Western diet-induced nonalcoholic steatohepatitis. J. Nutr. 143, 315\u2013323 (2013).","journal-title":"J. Nutr."},{"key":"41130_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29222-y","volume":"8","author":"S Jeyapal","year":"2018","unstructured":"Jeyapal, S. et al. Substitution of linoleic acid with \u03b1-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitis. Sci. Rep. 8, 10953 (2018).","journal-title":"Sci. Rep."},{"key":"41130_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01297-9","volume":"21","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: Critical role of liver-adipose axis. Cell Commun. Signal. 21, 268 (2023).","journal-title":"Cell Commun. Signal."},{"key":"41130_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-nutr-082018-124250","volume":"39","author":"B Koletzko","year":"2019","unstructured":"Koletzko, B. et al. FADS1 and FADS2 polymorphisms modulate fatty acid metabolism and dietary impact on health. Annu. Rev. Nutr. 39, 21\u201344 (2019).","journal-title":"Annu. Rev. Nutr."},{"key":"41130_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094836","volume":"25","author":"DT Ghooray","year":"2024","unstructured":"Ghooray, D. T., Xu, M., Shi, H., McClain, C. J. & Song, M. Hepatocyte-specific Fads1 overexpression attenuates Western diet-induced metabolic phenotypes in a rat model. Int. J. Mol. Sci. 25, 4836 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"41130_CR56","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nm1662","volume":"13","author":"T Matsuzaka","year":"2007","unstructured":"Matsuzaka, T. et al. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat. Med. 13, 1193\u20131202 (2007).","journal-title":"Nat. Med."},{"key":"41130_CR57","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1002\/hep.25932","volume":"56","author":"T Matsuzaka","year":"2012","unstructured":"Matsuzaka, T. et al. Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 56, 2199\u20132208 (2012).","journal-title":"Hepatology"},{"key":"41130_CR58","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.3390\/jcm11133842","volume":"11","author":"J Mart\u00ednez-Sanz","year":"2022","unstructured":"Mart\u00ednez-Sanz, J. et al. Effects of HIV infection in plasma free fatty acid profiles among people with non-alcoholic fatty liver disease. J. Clin. Med. 11, 3842 (2022).","journal-title":"J. Clin. Med."},{"key":"41130_CR59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1194\/jlr.M800383-JLR200","volume":"50","author":"Y-A Moon","year":"2009","unstructured":"Moon, Y.-A., Hammer, R. E. & Horton, J. D. Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J. Lipid Res. 50, 412\u2013423 (2009).","journal-title":"J. Lipid Res."},{"key":"41130_CR60","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1194\/jlr.M050062","volume":"55","author":"S Tripathy","year":"2014","unstructured":"Tripathy, S. et al. Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL\/6J mice. J. Lipid Res. 55, 1448\u20131464 (2014).","journal-title":"J. Lipid Res."},{"key":"41130_CR61","first-page":"-","volume":"731","author":"M Hirao-Suzuki","year":"2022","unstructured":"Hirao-Suzuki, M., Takayuki, K., Takiguchi, M., Peters, J. M. & Takeda, S. Cannabidiolic acid activates the expression of the PPAR\u03b2\/\u03b4 target genes in MDA-MB-231 cells. Arch. Biochem. Biophys. 731, 109428 (2022).","journal-title":"Arch. Biochem. Biophys.\u00a0"},{"key":"41130_CR62","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbagen.2019.01.002","volume":"1863","author":"E D'Aniello","year":"2019","unstructured":"D\u2019Aniello, E. et al. Identification and characterization of phytocannabinoids as novel dual PPAR\u03b1\/\u03b3 agonists by a computational and in vitro experimental approach. Biochimica et Biophysica Acta (BBA) - General Subjects 1863, 586\u2013597 (2019).","journal-title":"Biochimica et Biophysica Acta (BBA) - General Subjects"},{"key":"41130_CR63","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","volume":"385","author":"SM Francque","year":"2021","unstructured":"Francque, S. M. et al. A randomized, controlled trial of the pan-PPAR agonist Lanifibranor in NASH. N. Engl. J. Med. 385, 1547\u20131558 (2021).","journal-title":"N. Engl. J. Med."},{"key":"41130_CR64","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1016\/j.cgh.2020.10.051","volume":"19","author":"MS Siddiqui","year":"2021","unstructured":"Siddiqui, M. S. et al. A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology. 19, 2670\u20132672 (2021).","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"41130_CR65","doi-asserted-by":"publisher","unstructured":"Taweesap, P. et al. Luteolin relieves metabolic dysfunction-associated fatty liver disease caused by a high-fat diet in rats through modulating the AdipoR1\/AMPK\/PPAR\u03b3 signaling pathway. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms26083804. (2025).","DOI":"10.3390\/ijms26083804"},{"key":"41130_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1139\/apnm-2016-0088","volume":"42","author":"P Prabhakar","year":"2017","unstructured":"Prabhakar, P., Reeta, KH., Maulik, S. K., Dinda, A. K. & Gupta, Y. K. \u03b1-Amyrin attenuates high fructose diet-induced metabolic syndrome in rats. Applied Physiology, Nutrition, and Metabolism. 42, 23\u201332 (2017).","journal-title":"Applied Physiology, Nutrition, and Metabolism"},{"key":"41130_CR67","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1194\/jlr.M800105-JLR200","volume":"49","author":"NE Freeman-Anderson","year":"2008","unstructured":"Freeman-Anderson, N. E. et al. Cannabinoid (CB2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL\/oxysterol-induced apoptosis. J. Lipid Res. 49, 2338\u20132346 (2008).","journal-title":"J. Lipid Res."},{"key":"41130_CR68","doi-asserted-by":"crossref","unstructured":"Mendez-Sanchez, N. et al. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease. Liver International. 27, 215\u2013219 (2007).","DOI":"10.1111\/j.1478-3231.2006.01401.x"},{"key":"41130_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12019-w","volume":"7","author":"D Nowacki","year":"2017","unstructured":"Nowacki, D. et al. Lecithin derived from \u03c9-3 PUFA fortified eggs decreases blood pressure in spontaneously hypertensive rats. Sci. Rep. 7, 12373 (2017).","journal-title":"Sci. Rep."},{"key":"41130_CR70","doi-asserted-by":"publisher","first-page":"533","DOI":"10.22358\/jafs\/68075\/2000","volume":"9","author":"B Pastuszewska","year":"2000","unstructured":"Pastuszewska, B., Ochtabi\u0144ska, A. & Morawski, A. A note on the nutritional adequacy of stock diets for laboratory rats and mice. J. Anim. Feed Sci. 9, 533\u2013542 (2000).","journal-title":"J. Anim. Feed Sci."},{"key":"41130_CR71","unstructured":"https:\/\/researchdiets.com\/formulas\/d12492 ."},{"key":"41130_CR72","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/biom9120877","volume":"9","author":"A Zalewska","year":"2019","unstructured":"Zalewska, A., Maciejczyk, M., Szulimowska, J., Imierska, M. & B\u0142achnio-Zabielska, A. High-fat diet affects ceramide content, disturbs mitochondrial redox balance, and induces apoptosis in the submandibular glands of mice. Biomolecules. 9, 877 (2019).","journal-title":"Biomolecules"},{"key":"41130_CR73","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1007\/s00213-018-5034-1","volume":"235","author":"EM Rock","year":"2018","unstructured":"Rock, E. M., Limebeer, C. L. & Parker, L. A. Effect of cannabidiolic acid and \u22069-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain. Psychopharmacology. 235, 3259\u20133271 (2018).","journal-title":"Psychopharmacology"},{"key":"41130_CR74","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1111\/bph.14019","volume":"174","author":"X Nadal","year":"2017","unstructured":"Nadal, X. et al. Tetrahydrocannabinolic acid is a potent PPAR\u03b3 agonist with neuroprotective activity. Br. J. Pharmacol. 174, 4263\u20134276 (2017).","journal-title":"Br. J. Pharmacol"},{"key":"41130_CR75","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem"},{"key":"41130_CR76","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.3390\/ijms23105382","volume":"23","author":"K Berk","year":"2022","unstructured":"Berk, K., Konstantynowicz-Nowicka, K., Charytoniuk, T., Harasim-Symbor, E. & Chabowski, A. Distinct effects of Cannabidiol on sphingolipid metabolism in subcutaneous and visceral adipose tissues derived from high-fat-diet-fed male Wistar rats. Int. J. Mol. Sci. 23, 5382 (2022).","journal-title":"J. Mol. Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41130-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41130-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41130-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T11:04:35Z","timestamp":1773227075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41130-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41130"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41130-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the EU Directive 2010\/63\/EU for animal experiments and approved by the Ethical Committee for Animal Testing in Olsztyn, Poland (permission no. 35\/2023, date of approval: 19 April 2023).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"8670"}}